Denosumab for management of parathyroid carcinoma-mediated hypercalcemia. [electronic resource]
- The Journal of clinical endocrinology and metabolism Feb 2014
- 387-90 p. digital
Publication Type: Case Reports; Journal Article; Research Support, N.I.H., Extramural
1945-7197
10.1210/jc.2013-3031 doi
Adult Antibodies, Monoclonal, Humanized--therapeutic use Carcinoma--complications Denosumab Humans Hypercalcemia--drug therapy Male Parathyroid Neoplasms--complications Treatment Outcome